Roebuck M Christopher
M. Christopher Roebuck, PhD, MBA, 11350 McCormick Rd., Executive Plaza II, Ste. 705, Hunt Valley, MD 21031, USA.
J Manag Care Spec Pharm. 2014 Oct;20(10):994-5. doi: 10.18553/jmcp.2014.20.10.994.
This brief commentary extends earlier work on the value of adherence to derive medical cost offset estimates from prescription drug utilization. Among seniors with chronic vascular disease, 1% increases in condition-specific medication use were associated with significant (P less than 0.001) reductions in gross nonpharmacy medical costs in the amounts of 0.63% for dyslipidemia, 0.77% for congestive heart failure, 0.83% for diabetes, and 1.17% for hypertension.
本简短评论扩展了早期关于依从性价值的研究工作,以从处方药使用情况中得出医疗成本抵消估计值。在患有慢性血管疾病的老年人中,特定疾病药物使用量增加1%与非药房总医疗成本显著(P < 0.001)降低相关,血脂异常降低0.63%,充血性心力衰竭降低0.77%,糖尿病降低0.83%,高血压降低1.17%。